30 September 2025
DLA Piper advises on Hong Kong IPO of 160 Health, China’s leading digital healthcare integrated service provider
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| George Wu Lead | DLA Piper | Partner | Equity Capital Markets | Not stated |
| Jack Li | DLA Piper | Senior associate | Not stated | Hong Kong |
| Jessica Sun | DLA Piper | Other | Not stated | Hong Kong |
| Yu Sun | DLA Piper | Other | Not stated | Hong Kong |
| Marcus Ng | DLA Piper | Associate | Not stated | Hong Kong |
| Ivy Chung | DLA Piper | Other | Not stated | Hong Kong |
| Nicholas Chan | DLA Piper | Other | Not stated | Hong Kong |
| Lily Choi | DLA Piper | Other | Not stated | Hong Kong |
| Bernie Wong | DLA Piper | Trainee | Not stated | Hong Kong |
| Charlotte Wang | DLA Piper | Other | Not stated | Shanghai |
| Sophia Sun | Shanghai Kaiman Law Firm | Associate | Not stated | Shanghai |
Stated terms
- Stated value
- HKD 400m (approximately HKD 400 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- 160 Health International Limited (Issuer)
Shenwan Hongyuan Capital (H.K.) Limited (Underwriters)
Zero2IPO Capital Limited (Underwriters)